Oncologists Accepting Harvard Pilgrim Health Care
466 verified oncologists across the U.S. accept Harvard Pilgrim Health Care. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Newton-wellesley Hospital.


Ursula Matulonis, MD
Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute
Oncology


Robert Haddad, MD
Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School
Oncology


Mary-Ellen Taplin, MD
Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Oncology


Toni Choueiri, M.D.
Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School
Oncology


Ann Lacasce, M.D.
Associate Professor of Medicine, is a lymphoma specialist and is the Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. She serves
Oncology


Susana Campos, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Oncology


Suzanne George, MD
Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School
Oncology


Himisha Beltran, MD
Associate Professor of Medicine, Lank Center for Genitourinary Oncology and Division of Molecular and Cellular Oncology; Director of Translational Research, Medical Oncology
Oncology


Joseph Antin, MD
Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus
Oncology


Geoffrey Shapiro, MD PHD
Senior Vice President, Developmental Therapeutics; Clinical Director, Center for DNA Damage and Repair; Professor of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute
Oncology


Robert Soiffer, MD
Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Oncology


Harold Burstein, MD PHD
Director of Academic Partnerships; Director of Breast Cancer Education
Oncology


Suzanne Lentzsch, MD
Professor of Medicine; Director, Multiple Myeloma and Amyloidosis Program
Oncology


Stuart Schnitt, M.D.
Chief of Oncologic Pathology at the Dana-Farber Cancer Institute, Professor of Pathology at Harvard Medical School, and is an internationally recognized ex; Chief of Oncologic Pathology
Oncology


Howard Kaufman, M.D.
Professor, Surgery
Oncology


Arnold Freedman, MD
Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School
Oncology


Jedd Wolchok, MD
Meyer Director, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine
Oncology


Erica Mayer, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program
Oncology


Andrea Ng, MD
Director, Lymphoma/Hematologic Radiation Oncology
Oncology


Jennifer Ligibel, MD
Professor at Harvard Medical School and a Senior Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on; Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living and has built a comprehensive clinical Healthy Living Program for patient
Oncology
Oncologists accepting Harvard Pilgrim Health Care by state
Find oncologists who accept Harvard Pilgrim Health Care in your state.